141 related articles for article (PubMed ID: 11448466)
1. Ovarian function during use of vaginal rings delivering three different doses of Nestorone.
Brache V; Mishell DR; Lahteenmaki P; Alvarez F; Elomaa K; Jackanicz T; Faundes A
Contraception; 2001 May; 63(5):257-61. PubMed ID: 11448466
[TBL] [Abstract][Full Text] [Related]
2. Ovarian function during use of Nestorone(R) subdermal implants.
Brache V; Massai R; Mishell DR; Moo-Young AJ; Alvarez F; Salvatierra AM; Cochon L; Croxatto H; Robbins A; Faundes A
Contraception; 2000 Mar; 61(3):199-204. PubMed ID: 10827334
[TBL] [Abstract][Full Text] [Related]
3. Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.
Fraser IS; Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Tsong YY; Sivin I
Contraception; 2005 Jul; 72(1):40-5. PubMed ID: 15964291
[TBL] [Abstract][Full Text] [Related]
4. Bone turnover markers in women participating in a dose-finding trial of a contraceptive vaginal ring releasing Nestorone and estradiol.
Tiedeken M; Westhoff CL; Cohen A; Cremers S; Sitruk-Ware R; Blithe DL;
Contraception; 2019 Jun; 99(6):329-334. PubMed ID: 30871934
[TBL] [Abstract][Full Text] [Related]
5. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
[TBL] [Abstract][Full Text] [Related]
8. Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study.
Jensen JT; Edelman AB; Chen BA; Archer DF; Barnhart KT; Thomas MA; Burke AE; Westhoff CL; Wan LS; Sitruk-Ware R; Kumar N; Variano B; Blithe DL
Contraception; 2018 May; 97(5):422-427. PubMed ID: 29409834
[TBL] [Abstract][Full Text] [Related]
9. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS
Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial.
Sivin I; Mishell DR; Alvarez F; Brache V; Elomaa K; Lähteenmäki P; Massai R; Miranda P; Croxatto H; Dean C; Small M; Nash H; Jackanicz TM
Contraception; 2005 Feb; 71(2):122-9. PubMed ID: 15707562
[TBL] [Abstract][Full Text] [Related]
11. A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings.
Fraser IS; Weisberg E; Minehan E; Johansson ED
Contraception; 2000 Apr; 61(4):241-51. PubMed ID: 10899479
[TBL] [Abstract][Full Text] [Related]
12. Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding study.
Haukkamaa M; Laurikka-Routti M; Heikinheimo O; Moo-Young A
Contraception; 1992 Jan; 45(1):49-55. PubMed ID: 1591921
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial with Nestorone subdermal contraceptive implants.
Díaz S; Schiappacasse V; Pavez M; Zepeda A; Moo-Young AJ; Brandeis A; Lähteenmäki P; Croxatto HB
Contraception; 1995 Jan; 51(1):33-8. PubMed ID: 7750282
[TBL] [Abstract][Full Text] [Related]
14. Feasibility study of Nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception.
Croxatto HB; Brache V; Massai R; Alvarez F; Forcelledo ML; Pavez M; Cochon L; Salvatierra AM; Faundes A
Contraception; 2006 Jan; 73(1):46-52. PubMed ID: 16371294
[TBL] [Abstract][Full Text] [Related]
15. A dose-finding, cross-over study to evaluate the effect of a Nestorone®/Estradiol transdermal gel delivery on ovulation suppression in normal ovulating women.
Brache V; Merkatz R; Kumar N; Jesam C; Sussman H; Hoskin E; Roberts K; Alami M; Taylor D; Jorge A; Croxatto H; Lorange E; Mishell DR; Sitruk-Ware R
Contraception; 2015 Oct; 92(4):289-97. PubMed ID: 26032952
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
18. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
[TBL] [Abstract][Full Text] [Related]
19. Effects of concurrent vaginal miconazole treatment on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol delivered from a contraceptive vaginal ring: a randomized, crossover drug-drug interaction study.
Simmons KB; Kumar N; Plagianos M; Roberts K; Hoskin E; Han L; Alami M; Creasy G; Variano B; Merkatz R
Contraception; 2018 Mar; 97(3):270-276. PubMed ID: 29097225
[TBL] [Abstract][Full Text] [Related]
20. Contraceptive vaginal rings.
Harwood B; Mishell DR
Semin Reprod Med; 2001 Dec; 19(4):381-90. PubMed ID: 11727180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
